Authors: CARLSSON R BOLLING E JERNDAL P JUNGHARD O LAURITSEN K GLISE H

Citation: R. Carlsson et al., FACTORS PREDICTING RESPONSE TO OMEPRAZOLE TREATMENT IN PATIENTS WITH FUNCTIONAL DYSPEPSIA, Gastroenterology, 110(4), 1996, pp. 76-76

Authors: LAURITSEN K AALYKKE C HAVELUND T KNUDSEN T GLISE H UNGE P EKSTROM P JAUP B NORRBY A STUBBEROD A MELEN K BOLLING E JERNDAL P JUNGHARD O

Citation: K. Lauritsen et al., EFFECT OF OMEPRAZOLE IN FUNCTIONAL DYSPEPSIA - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY, Gastroenterology, 110(4), 1996, pp. 702-702

Authors: PORRO GB CORINALDESI R LAZZARONI M BARBARA L CAPURSO L PAOLUZI P MANGIAMELI A SABBATINI F FRANCESCHI M BOLLING E

Citation: Gb. Porro et al., LONG-TERM TREATMENT WITH OMEPRAZOLE 20 MG 3 DAYS A WEEK OR 10 MG DAILY IN THE PREVENTION OF DUODENAL-ULCER RELAPSE, Alimentary pharmacology & therapeutics, 8(5), 1994, pp. 541-548

Authors: LAURITSEN K RUTGERSSON K BOLLING E BRUNNER G ERIKSSON S GALMICHE JP THOMSON ABR WALAN A ARCHAMBAULT A GUDJONSSON H BAILEY R PORRO B FRISON L HAVU N

Citation: K. Lauritsen et al., OMEPRAZOLE OR RANITIDINE IN DUODENAL-ULCER PREVENTION - DOUBLE-BLIND COMPARATIVE TRIAL, Gastroenterology, 104(4), 1993, pp. 130-130